期刊文献+

Lewis肺癌细胞趋化因子受体CXCR4表达的研究 被引量:2

Expression of chemokine receptor CXCR4 in Lewis lung carcinoma cells
下载PDF
导出
摘要 目的:观察趋化因子受体CXCR4在Lewis肺癌细胞和肿瘤组织中的表达,为探讨CXCR4与肿瘤转移的关系提供研究基础。方法:体外培养Lewis肺癌细胞,并建立Lewis肺癌细胞皮下种植瘤模型与自发性转移模型,采用RT-PCR和蛋白质印迹法分析培养细胞和肿瘤组织中CXCR4 mRNA及蛋白质表达水平;应用免疫组化方法分析Lewis肺癌原发瘤和转移瘤中CXCR4表达,并通过迁移实验观察CXCR4特异性配体SDF-1α对Lewis肺癌细胞的趋化作用。结果:培养Lewis肺癌细胞及肿瘤组织中均功能性地表达趋化因子受体CXCR4,且其表达水平与细胞所处氧环境有关;低氧能够促使Lewis肺癌细胞CXCR4蛋白表达增高,与对照组相比差异有统计学意义,t=4.051,P=0.009。12h细胞趋化运动实验显示,CXCR4特异性配体SDF-1α可剂量依赖性诱导Lewis肺癌细胞的趋化运动,在低氧条件下,同对照组相比SDF-1α质量浓度为25ng/mL时开始促进细胞迁移,t=3.053,P=0.031;SDF-1α质量浓度为50ng/mL时可明显提高细胞迁移率,t=4.521,P=0.004。结论:Lewis肺癌细胞功能性表达趋化因子受体CX-CR4,可能与肿瘤细胞迁移和转移有关。 OBJECTIVE: To explore the expression of chemokine receptor CXCR4 in Lewis lung carcinoma and build the basis for investigating the relationship between the receptor and tumor metastasis. METHODS: The mRNA level and protein expression of chemokine receptor CXCR4 were detected by RT-PCR and Western blot. Immunohistochemistry assay was performed to evaluate the expression of CXCR4 in primary and metastatic tumor of Lewis lung carcinoma. The cell chemotactic mobility responding to SDF-1α, the specific ligand of CXCR4, was analyzed by migration assay. RESULTS: Expression of CXCR4 in Lewis lung carcinoma was proved in vivo and in vitro, and was related to oxygen concentration of cell niche. In hypoxic condition the expression of CXCR4 mRNA and protein in Lewis lung carcinoma was upregulated significantly, t=4. 051,P=0. 009. Moreover, migratory response of Lewis lung carcinoma cells could be induced by SDF-1α, the specific ligand of CXCR4. After treated with 25 ng/mL SDF1-α for 12 hours, the rate of migration was increased, t=3.053, P=0.031. And with 50 ng/mL SDF1-α, the rate of migration was increased significantly, t = 4. 521, P= 0. 004. CONCLUSION: These results suggeste that CXCR4 is functionally expressed in Lewis lung carcinoma cells and possibly involved in tumor cell migration and metastasis.
出处 《中华肿瘤防治杂志》 CAS 2008年第17期1281-1284,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30570372 30700120) 广东省科技计划项目(2005A10902003 2006B35502001) 广东省医学科研基金(B2005021)
关键词 Lewis肺 受体 趋化因子 免疫组织化学 carcinoma, Lewis lung receptors, chemokine immunohistochemistry
  • 相关文献

参考文献10

  • 1Murdoch C. CXCR4 : chemokine receptor extraordinaire[J]. Immunol Rev, 2000, 177(1): 175-184.
  • 2Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis [J]. Nature, 2001, 410(6824): 50- 56.
  • 3Epstein R J. The CXCL12-CXCR4 chemotaetic pathway as a target of adjuvant breast cancer therapies [J]. Nat Rev Cancer, 2004, 4(11) :901-909.
  • 4Tamamura H, Hori A, Kanzaki N, et al. T140 analogs as CXCR4 antagonists identified as anti metastatic agents in the treatment of breast cancer[J]. FEBS Lett, 2003, 550(1-3): 79-83.
  • 5O'Reilly M S, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [J]. Cell, 1994, 79(2): 315-328.
  • 6Burger J A, Kipps T J, CXCR4 : a key receptor in the crosstalk between tumor cells and their microenvironment [J]. Blood, 2006, 107(5):1761-1767.
  • 7Lapteva N, Yang A G, Sanders D E, et al. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo [J]. Cancer Gene Ther, 2005, 12(1) :84-89.
  • 8Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4 [J]. Semin Cancer Biol, 2004, 14(3) :171-179.
  • 9Kaplan R N, Riba R D, Zaeharoulis S, et al. VEGFR1 positive haematopoietic bone marrow progenitors initiate the pre meta static niche[J]. Nature, 2005, 438(7069):820-827.
  • 10Zagzag D, Lukyanov Y, Lan L, et al. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion [J]. Lab Invest, 2006, 86(12) :1221-1232.

同被引文献13

  • 1蒋玉萍,吴小华.趋化因子CXCL12及其受体与肿瘤转移的关系[J].癌症,2007,26(2):220-224. 被引量:21
  • 2尹扬光,黄岚,赵晓辉,于世勇,方玉强,赵景红.SDF-1对内皮祖细胞增殖迁移的影响及AMD3100对其的干预[J].第三军医大学学报,2007,29(6):475-478. 被引量:11
  • 3Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4[J]. Semin Cancer Biol, 2004, 14(3) : 171 -179.
  • 4Fricker S P, Anastassov V, Cox J, et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4 [J].Biochem Pharmacol, 2006, 72(5) : 588 -596.
  • 5Broxmeyer H E, Orschell C M, Clapp D W, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist [ J ]. J Exp Med, 2005, 201 ( 8 ) : 1307 - 1318.
  • 6Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis [ J ]. Trends Immunol, 2007, 28(7) : 299 -307.
  • 7Orimo A, Gupta P B, Sgroi D C, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion [ J ]. Cell, 2005, 121 (3) : 335 - 348.
  • 8Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells [ J ]. Cell, 2006, 124(1) : 175 -189.
  • 9Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis[J]. Nature, 2001,410(6824) : 50 -56.
  • 10Yasumoto K, Koizumi K, Kawashima A, et al. Role of the CXCL12/ CXCR4 axis in peritoneal carcinomatosis of gastric cancer[J]. Cancer Res, 2006, 66(4) : 2181 -2187.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部